SeattleNTCSeattleNTC Facebook ad: “SeattleNTC, Neuropsychiatric Treatment Center”
Ran for 807 days, from March 20, 2024 to June 5, 2026, the last day Crush saw it.
Run by SeattleNTC on Facebook. Crush is not the advertiser and does not verify its claims. See this ad in Meta's Ad Library(opens in a new tab)
Want an ad like this for your product?
Crush makes new ad images for your product from this ad: your logo, your product photo, your offer.
Trials from $19.95 USD, then $79.95 USD a month. Cancel anytime.
About this ad
- Meta Ad Library ID
- 947476733441879
- Platforms
- Facebook, Instagram, Audience Network and Messenger
- Relaunches
- 0
Ad text
Do you or someone you know struggle with major depressive disorder? There is a new research option that may improve your symptoms and quality of life. If so, you may qualify to participate in our clinical research program using the SAINT™ neuromodulation system. The SAINT neuromodulation system is a novel investigational technology that uses non invasive magnetic stimulation to target specific areas of the brain associated with depression. Our clinical research program aims to further investigate the safety and efficacy of the SAINT neuromodulation system in a larger group of patients with major depressive disorder in a real-world setting. To qualify for the study, you must be 18 years or older, have a diagnosis of major depressive disorder, and have tried at least one antidepressant medication without satisfactory improvement. To learn more about the SAINT neuromodulation system clinical research program and how to see if you qualify, visit our website or contact us today. Email [email protected] or call 206-467-6300 ext. 5
Where the ad sends people
seattlentc.com
SeattleNTC – Neuropsychiatric Treatment Center
Learn more: seattlentc.com(opens in a new tab)
